AIBMR Life Sciences, Inc.

AIBMR is a scientific and regulatory consulting firm, founded in 1978. AIBMR offers key services specifically tailored to the natural products industry, including GRAS Independent Conclusions, FDA GRAS & NDI Notifications, toxicology studies, acute cosmetic studies, exposure estimates, label reviews, claims substantiation, FDA & FTC compliance, and manuscript preparation & publication. AIBMR is also an industry leader in hemp & cannabinoids research, with expertise in CBD safety assessments and regulatory status for foods and dietary supplements. In 2018, AIBMR and global toxicology lab partner, Toxi-Coop, performed a landmark comprehensive toxicological safety assessment on a natural CBD-containing hemp extract, marking the first time in 38 years that this had been accomplished. AIBMR then completed a GRAS Conclusion, providing the first proper regulatory status for a CBD-containing hemp extract in this fast-growing industry. AIBMR continues to monitor hemp regulations and the US marketplace, in general.